MedTrace Logo

Refugee Insect Production for Food and Feed: the School Meal Intervention

NCT06739629 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 342

Last updated 2024-12-27

No results posted yet for this study

Summary

The goal of this randomized controlled trial is to assess whether edible insect-enriched school porridge has nutrition and health benefits for children aged 6-9 years in refugee communities in Uganda.

The main question the research aims to answer is: Does a daily serving of maize porridge enriched with yellow mealworm flour improve the gut health, growth, and micronutrient status of children in comparison to a standard maize porridge?

Participants will:

Consume a daily serving of yellow mealworm porridge or a maize porridge for one school term (3 months). Data is collected before, during and after the intervention period.

Conditions

  • Nutrition, Healthy

Interventions

OTHER

Insect porridge

Yellow mealworm porridge

OTHER

Maize Porridge

Maize porridge

Sponsors & Collaborators

  • Makerere University

    collaborator OTHER

  • International Centre of Insect Physiology and Ecology (ICIPE)

    collaborator OTHER

  • Mothers Against Malnutrition and Hunger

    collaborator UNKNOWN

  • Child and Family Health, Uganda

    collaborator UNKNOWN

  • Research and Action for Income Security

    collaborator UNKNOWN

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Ezekiel Mupere, PhD, MD · Makerere University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-17
Primary Completion
2024-10-25
Completion
2024-10-25

Countries

  • Uganda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06739629 on ClinicalTrials.gov